Aubin Michalon
Schlieren, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial.
Journal: Nature medicine
Published: September 18, 2025
Prediction of Cardiac ATTR Depletion by NI006 (ALXN2220) Using Mechanistic PK/PD Modeling.
Journal: Clinical pharmacology and therapeutics
Published: May 15, 2024
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.
Journal: The New England journal of medicine
Published: May 22, 2023
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells.
Journal: Nature communications
Published: August 24, 2020
Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.
Journal: Cerebellum (London, England)
Published: June 10, 2016
Drug discovery for autism spectrum disorder: challenges and opportunities.
Journal: Nature reviews. Drug discovery
Published: October 02, 2013
Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Journal: Biological psychiatry
Published: September 18, 2012
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.
Journal: Neuron
Published: March 12, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026